A Study to Evaluate the Safety and Reactogenicity of DPX-RSV(A), a Respiratory Syncytial Virus Vaccine
Condition(s):Respiratory Syncytial VirusLast Updated:February 5, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Respiratory Syncytial VirusLast Updated:February 5, 2020Completed
Condition(s):HealthyLast Updated:September 7, 2023Completed
Condition(s):Ebola VirusesLast Updated:February 9, 2016Completed
Condition(s):Failing Dental Composite RestorationsLast Updated:June 22, 2016Withdrawn
Condition(s):InfluenzaLast Updated:May 27, 2015Completed
Condition(s):Attention Deficit Hyperactivity Disorder (ADHD)Last Updated:March 28, 2014Completed
Condition(s):InfluenzaLast Updated:March 30, 2018Completed
Condition(s):Vaccine Exposure During PregnancyLast Updated:January 19, 2017Terminated
Condition(s):Gastrointestinal DiseasesLast Updated:February 4, 2022Completed
Condition(s):InfluenzaLast Updated:June 15, 2011Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.